Investigation of serum Cu, Zn-SOD concentration by ELISA and histological localization in hepatocellular carcinoma (HCC) using anti-human Cu, Zn-SOD monoclonal antibody

Isao Sakaida, Keiki Ogino, Shinji Oka, Shinjiro Matsuura, Shunji Yoshimura, Kazuya Matsuda, Toshiyuki Sasaki, Kasunari Yamamoto, Keiiiro Ando, Yohei Fukumoto, Kiwamu Okita, Yukinori Okazaki, Tadayoshi Takemoto, Taizo Uda

Research output: Contribution to journalArticle

Abstract

Serum Cu, Zn-SOD concentration and histological localization of patients with HCC were examined using anti-human Cu, Zn-SOD monoclonal antibody. The serum Cu, Zn-SOD concentration of patients with HCC was significantly elevated compared with healthy adults and also patients with liver cirrhosis but there was no correlation between serum Cu, Zn-SOD and serum GPT, GOT, AFP values. There are many reports that diminishing amounts of Cu, Zn-SOD activity were found in tumors, but our histological results show that in about 20% of our specimens Cu, Zn-SOD was strongly stained in tumors. This may indicae that amounts of Cu, Zn-SOD were quantitatively increased in tumors. These results suggest that it is possible for Cu, Zn-SOD to be a new marker for HCC and a possible reason for the existence of anti-cancer drug resistant HCC, for example such as adriamycin which kills the tumor cells mainly with active oxygen.

Original languageEnglish
Pages (from-to)1211-1218
Number of pages8
JournalKanzo
Volume28
Issue number9
DOIs
Publication statusPublished - 1987
Externally publishedYes

Fingerprint

Hepatocellular Carcinoma
Enzyme-Linked Immunosorbent Assay
Monoclonal Antibodies
Serum
Neoplasms
Liver Cirrhosis
Doxorubicin
Reactive Oxygen Species
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Hepatology

Cite this

Investigation of serum Cu, Zn-SOD concentration by ELISA and histological localization in hepatocellular carcinoma (HCC) using anti-human Cu, Zn-SOD monoclonal antibody. / Sakaida, Isao; Ogino, Keiki; Oka, Shinji; Matsuura, Shinjiro; Yoshimura, Shunji; Matsuda, Kazuya; Sasaki, Toshiyuki; Yamamoto, Kasunari; Ando, Keiiiro; Fukumoto, Yohei; Okita, Kiwamu; Okazaki, Yukinori; Takemoto, Tadayoshi; Uda, Taizo.

In: Kanzo, Vol. 28, No. 9, 1987, p. 1211-1218.

Research output: Contribution to journalArticle

Sakaida, I, Ogino, K, Oka, S, Matsuura, S, Yoshimura, S, Matsuda, K, Sasaki, T, Yamamoto, K, Ando, K, Fukumoto, Y, Okita, K, Okazaki, Y, Takemoto, T & Uda, T 1987, 'Investigation of serum Cu, Zn-SOD concentration by ELISA and histological localization in hepatocellular carcinoma (HCC) using anti-human Cu, Zn-SOD monoclonal antibody', Kanzo, vol. 28, no. 9, pp. 1211-1218. https://doi.org/10.2957/kanzo.28.1211
Sakaida, Isao ; Ogino, Keiki ; Oka, Shinji ; Matsuura, Shinjiro ; Yoshimura, Shunji ; Matsuda, Kazuya ; Sasaki, Toshiyuki ; Yamamoto, Kasunari ; Ando, Keiiiro ; Fukumoto, Yohei ; Okita, Kiwamu ; Okazaki, Yukinori ; Takemoto, Tadayoshi ; Uda, Taizo. / Investigation of serum Cu, Zn-SOD concentration by ELISA and histological localization in hepatocellular carcinoma (HCC) using anti-human Cu, Zn-SOD monoclonal antibody. In: Kanzo. 1987 ; Vol. 28, No. 9. pp. 1211-1218.
@article{a0944a49b1244471901a85d86fde338d,
title = "Investigation of serum Cu, Zn-SOD concentration by ELISA and histological localization in hepatocellular carcinoma (HCC) using anti-human Cu, Zn-SOD monoclonal antibody",
abstract = "Serum Cu, Zn-SOD concentration and histological localization of patients with HCC were examined using anti-human Cu, Zn-SOD monoclonal antibody. The serum Cu, Zn-SOD concentration of patients with HCC was significantly elevated compared with healthy adults and also patients with liver cirrhosis but there was no correlation between serum Cu, Zn-SOD and serum GPT, GOT, AFP values. There are many reports that diminishing amounts of Cu, Zn-SOD activity were found in tumors, but our histological results show that in about 20{\%} of our specimens Cu, Zn-SOD was strongly stained in tumors. This may indicae that amounts of Cu, Zn-SOD were quantitatively increased in tumors. These results suggest that it is possible for Cu, Zn-SOD to be a new marker for HCC and a possible reason for the existence of anti-cancer drug resistant HCC, for example such as adriamycin which kills the tumor cells mainly with active oxygen.",
author = "Isao Sakaida and Keiki Ogino and Shinji Oka and Shinjiro Matsuura and Shunji Yoshimura and Kazuya Matsuda and Toshiyuki Sasaki and Kasunari Yamamoto and Keiiiro Ando and Yohei Fukumoto and Kiwamu Okita and Yukinori Okazaki and Tadayoshi Takemoto and Taizo Uda",
year = "1987",
doi = "10.2957/kanzo.28.1211",
language = "English",
volume = "28",
pages = "1211--1218",
journal = "Acta Hepatologica Japonica",
issn = "0451-4203",
publisher = "Japan Society of Hepatology",
number = "9",

}

TY - JOUR

T1 - Investigation of serum Cu, Zn-SOD concentration by ELISA and histological localization in hepatocellular carcinoma (HCC) using anti-human Cu, Zn-SOD monoclonal antibody

AU - Sakaida, Isao

AU - Ogino, Keiki

AU - Oka, Shinji

AU - Matsuura, Shinjiro

AU - Yoshimura, Shunji

AU - Matsuda, Kazuya

AU - Sasaki, Toshiyuki

AU - Yamamoto, Kasunari

AU - Ando, Keiiiro

AU - Fukumoto, Yohei

AU - Okita, Kiwamu

AU - Okazaki, Yukinori

AU - Takemoto, Tadayoshi

AU - Uda, Taizo

PY - 1987

Y1 - 1987

N2 - Serum Cu, Zn-SOD concentration and histological localization of patients with HCC were examined using anti-human Cu, Zn-SOD monoclonal antibody. The serum Cu, Zn-SOD concentration of patients with HCC was significantly elevated compared with healthy adults and also patients with liver cirrhosis but there was no correlation between serum Cu, Zn-SOD and serum GPT, GOT, AFP values. There are many reports that diminishing amounts of Cu, Zn-SOD activity were found in tumors, but our histological results show that in about 20% of our specimens Cu, Zn-SOD was strongly stained in tumors. This may indicae that amounts of Cu, Zn-SOD were quantitatively increased in tumors. These results suggest that it is possible for Cu, Zn-SOD to be a new marker for HCC and a possible reason for the existence of anti-cancer drug resistant HCC, for example such as adriamycin which kills the tumor cells mainly with active oxygen.

AB - Serum Cu, Zn-SOD concentration and histological localization of patients with HCC were examined using anti-human Cu, Zn-SOD monoclonal antibody. The serum Cu, Zn-SOD concentration of patients with HCC was significantly elevated compared with healthy adults and also patients with liver cirrhosis but there was no correlation between serum Cu, Zn-SOD and serum GPT, GOT, AFP values. There are many reports that diminishing amounts of Cu, Zn-SOD activity were found in tumors, but our histological results show that in about 20% of our specimens Cu, Zn-SOD was strongly stained in tumors. This may indicae that amounts of Cu, Zn-SOD were quantitatively increased in tumors. These results suggest that it is possible for Cu, Zn-SOD to be a new marker for HCC and a possible reason for the existence of anti-cancer drug resistant HCC, for example such as adriamycin which kills the tumor cells mainly with active oxygen.

UR - http://www.scopus.com/inward/record.url?scp=85007738446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007738446&partnerID=8YFLogxK

U2 - 10.2957/kanzo.28.1211

DO - 10.2957/kanzo.28.1211

M3 - Article

AN - SCOPUS:85007738446

VL - 28

SP - 1211

EP - 1218

JO - Acta Hepatologica Japonica

JF - Acta Hepatologica Japonica

SN - 0451-4203

IS - 9

ER -